ARCHIVES

J&J To Eliminate Its Ortho Biotech Unit As FDA Considers Further Limits On ESAs.

This article is from The Cancer Letter archive.

Vol. 34 No. 17 | May 2, 2008

Download PDF Visit The Full Archive

Related Articles

Grand Jury Clears Eppley, Shubik

October 24, 1980

House Aims to End Budget Markup Early; Natcher Sees Most Difficult Year

June 26, 1992

Reimbursement: NCI, VA Begin Project On Clinical Trials Access For Veterans

January 17, 1997

Continuing Progress Reported On Breast Cancer Treatment; Mammography Controversy Cooled

November 26, 1976

CDC Contribution To National Dialogue Raises Questions About Ties With ACS.

September 22, 2000

In Brief: Kerman New President Of ACCC, David Johnson Names President Elect; Wyder Gets NY Award

March 20, 1981